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Abstract: Nails have a limited number of reactive patterns to disease. Accordingly, toenail changes of different
etiologies may mimic onychomycosis. OBJECTIVE: To determine the prevalence of toenail onychomycosis
among patients with leg ulcer and toenail abnormalities attending a dermatology clinic. METHODS: A cross-sec-
tional study was conducted through the analysis of clinical records and results of mycological examination.
RESULTS: A total of 81 patients were included, with a median age of 76.0 years. Most ulcers were of venous eti-
ology, followed by those of mixed and arterial pathogenesis. The mycological evaluation confirmed the diagno-
sis of onychomycosis in 27.2% of the patients. The etiologic agent was a dermatophyte in 59.1% of isolates in nail
samples, while Trichophyton interdigitale was the most frequent fungal species (40.9%). CONCLUSIONS: Most
toenail abnormalities in patients with chronic leg ulcer were not onychomycosis. This study highlights the impor-
tance of systematic mycological examination in these patients, in order to avoid overtreatment with systemic
antifungals, unnecessary costs and side effects.
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Nail abnormalities are prevalent worldwide.
Onychomycosis is the most common cause of toenail
deformations in adults, accounting for up to 50% of all
nail disorders.1-5 Onychomychosis has worldwide distri-
bution and is estimated to affect approximately 2-10% of
the general adult population in developed countries.5-
9 Predisposition factors are numerous and include
increasing age, humidity, occlusive footwear, repeated
nail trauma, genetic predisposition, and concurrent dis-
ease, such as tinea pedis, diabetes mellitus, poor periph-
eral circulation, and immunosuppression.3,5,10,11
Often a silent and overlooked fungal infection,
onychomycosis is a cause of morbidity when associat-
ed with wounds and bacterial, infectious complica-
tions, particularly in individuals with a compromised
health status.12-15 In addition, it can be a cause of psy-
chosocial stress.7,13,16 These facts often prompt treatment
with antifungals, without previous mycological evalu-
ation. Still, not all dystrophic nails are onychomyco-
sis,17-19 while inadvertent antifungal treatment has eco-
nomic costs and is associated with side effects.20
Toenail changes are frequently observed among
the subset of patients with vascular disease and
chronic leg ulcer. However, despite the increasing
propensity to toenail fungal colonization and ony-
chomycosis in patients with peripheral vascular dis-
ease, nail changes may also be the result of microan-
giopathy and subsequent chronic ischemia.17-19
The aim of the present study was to determine
the prevalence of toenail onychomycosis among
patients with active leg ulcer and toenail abnormalities.
A cross-sectional study with a nested case-con-
trol study  was conducted. Further, a convenience
sample included all adult patients with chronic active
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differences were assessed using the χ2 test. The risk
odds ratio (ROR) and a 95% confidence interval (CI)
for proportions were calculated using normal approx-
imation to the binomial distribution.
Eighty-one patients with chronic leg ulcer and
toenail changes were included, 48 women (59.3%) and
33 men (40.7%), aged 36-91 years (median age 76.0
years, P25; P75=66.5; 83.5). The median evolution time
for leg ulcers was 1.5  years (P25;P75=0.5;5.0).
Regarding etiology, most of the patients had venous
leg ulcers (63.0%), followed by mixed (14.8%) and
arterial ulcers (11.1%), as documented by Doppler
ultrasound. Accordingly, chronic venous insufficiency
(CVI) was the most frequent comorbidity (76.5%), and
the majority of the patients were overweight or obese
(71.6%). Other common associated diseases included
hypertension (58.0%), peripheral arterial disease
(PAD) (23.5%) and diabetes mellitus (22.2%), with an
average of 2.6±1.1 comorbidities per patient. Overall,
56.8% of the patients had more than one toenail abnor-
mality, with 75.3% presenting subungual hyperker-
atosis, 40.7%  onychauxis, 30.9%  total onychodystro-
phy, 19.8% onycholysis, 6.2% superficial leuconychia,
and 4.9% onychogryphosis  (Table 1). Eleven patients
(13.6%) had clinical signs suggestive of tinea pedis.
Mycological examination was positive in 24 of
the 81 patients. Twenty-two patients (27.2%) were
diagnosed  with onychomychosis (95% CI: 36.9%-
75.1%),  including 4 patients with concurrent tinea
pedis. The remaining two patients were diagnosed
tinea pedis, solely. Dermatophytes were the most
common cause of onychomycosis (n=13; 59.1% of all
isolates). Among dermatophytes,  Trichophyton inter-
leg ulcer and toenail changes, who attended a derma-
tology clinic during a six-month period, from May to
October 2011. Exclusion criteria were: 1) previous his-
tory of systemic or localized disease(s) with known
nail involvement; 2) confirmed diagnosis of toenail
onychomycosis in the preceding year; 3) treatment
with systemic or topical antifungals in the preceding
six months. Patients’ informed consent was required.
Data were collected in attendance, through clinical
record analysis and patient inquiry, guided by a spe-
cific questionnaire that included demographic data,
leg ulcer etiology and time of evolution, comorbidities
and toenail changes.
Mycological examinations were performed on
every patient. According to clinical observation, nail
specimens were obtained after scraping the nail plate
and/or nail bed with a sterilized scalpel. Whenever
clinically suggestive of tinea pedis, sole and interdigi-
tal web space skin scrapings were collected. Samples
were sent to a laboratory and mycological tests were
performed. Direct microscopy observation of fungal
structures in fresh material was conducted after
immersion in a solution containing potassium
hydroxide 40%. Additionally, samples were inoculat-
ed in a test tube with a modified Sabouraud medium,
supplemented with 0.05 g/L of chloramphenicol and
0.4g/L of cycloheximide (BBL™ Mycosel™ Agar - BD,
USA), and incubation was carried out at 24ºC. All cul-
tures were examined weekly for growth for up to four
weeks before declaring them negative. Patients with
positive direct microscopy and negative culture were
retested with new scrapings to exclude false nega-
tives. All negative tests were repeated to validate
results.  Subcultures, with specific growth mediums,
were used to aid in identifying dermatophyte and
yeast infections.  For the purposes of identification,
isolation temperatures were set at 24ºC for filamen-
tous fungi and Candida optimal growth. Each fungal
colony growing from inoculate pieces was identified
at least to the genus level, through analysis of macro-
scopic, distinctive colonial traits and/or observation
of microscopic, morphologic characteristics in lac-
tophenol blue solution on  light microscopy. In the
presence of yeasts, a chromogenic agar was used to
identify  directly Candida albicans. Its exclusion
prompted the use of the ID32C® system (bioMérieux,
France), in order to identify Candida species other
than Candida albicans. The identification of a dermato-
phyte, non-dermatophytic mould or yeast confirmed
the diagnosis of onychomycosis and/or tinea pedis.
The Statistical Package for Social Studies 20.0
was used for data analysis.  P  ≤ 0.05 was considered
statistically significant.  Results were evaluated by
descriptive statistics (using Kolmogorov-Smirnov test
of normality) and in the case of nominal variables, the
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Parameter n (%)
Comorbidity
Chronic venous insufficiency 62 76.5
Body Mass Index ≥ 25 58 71.6
Hypertension 47 58.0
Peripheral arterial disease 19 23.5
Diabetes mellitus 18 22.2
Smoking habits 7 8.6








Subungueal hyperkeratosis 61 75.3
Onychauxis 33 40.7
Total onychodystrophy 25 30.9
Onycholysis 16 19.8
Superficial leuconychia 5 6.2
Onychogryphosis 4 4.9
TABLE 1: Clinical data of examined patients (n=81)
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digitale was the leading identified species (69.2%), fol-
lowed by  Trichophyton rubrum  (30.8%).
Onychomycosis was due to yeasts in 6 patients (27.2%
of all isolates), most commonly caused by  Candida
parapsilosis (66.7%) (Table 2). Patients with superficial
leuconychia were more likely to have onychomycosis
(ROR 12.9, 95% CI: 1.4-122.8, P = 0.026). No statistical-
ly significant association was found between other
nail changes and presence of onychomycosis.
Similarly, no statistically significant association
was found between demographic and/or clinical data
(namely age, gender, comorbidities, ulcer evolution
time or etiology) and onychomycosis or fungal agent.
Most leg ulcers are a clinical manifestation of an
underlying primary or secondary vascular disease. As
verified in clinical practice, these patients frequently
present with nail changes suggesting onychomycosis.
Nevertheless, other than fungal colonization, patients
with leg ulcer may gather predisposing factors for nail
abnormalities, such as age and poor peripheral circu-
lation:
a) With respect to age, the normal structure of the
nail is altered in the elderly with changes in
color, thickness, flexibility and shape, and
impairment of function.4
b) Vascular abnormalities may bring about ony-
chopathy  per se.17-19 Reduced perfusion of the
lower extremities results in suboptimal oxy-
genation, and impaired metabolic exchange of
nutrients in the foot. This may not only trigger
nail changes and morphological abnormalities,
but also hinder nail growth, instigate progres-
sion of onychomycosis, and delay / prevent the
clearance of infection.13,21
The presence of PAD is not only a recognized
potential cause for nail dystrophy, but may also pre-
dispose to nail fungal infection. A study by Gupta
AK et al. suggested PAD as an independent predictor
of onychomycosis. In their study, mycological evi-
dence of onychomycosis was present in 64.9% of 74
patients with PAP.21
Likewise, CVI through venous microangiopathy
generates  ischemia of the skin, and trophic changes,
which include toenail abnormalities, mimicking ony-
chomycosis or predisposing to it.22-25 Moreover, as both
onychomycosis and venous insufficiency are more fre-
quent in the elderly, it is not uncommon to find toenail
fungal infection in patients with CVI. Sáez de Ocariz et
al. reported a high prevalence of nail changes (61.1%) in
36 patients aged under 60 with CVI.23 Onychomycosis
was the cause of these changes in 59.1%.  Shemer  et
al.  documented a higher prevalence (84.1%) of nail
deformations among 44 CVI patients, with onychomy-
cosis in 75.7% of the affected nails.24 In this later
study, clinical features were very similar in all patients
with nail changes, both for mycotic and nonmycotic
pathologies, and no statistically significant difference
could be found in the clinical presentation between
both groups. This emphasizes the fact that nails have a
limited number of reactive patterns to disease, hinder-
ing clinical diagnosis.17-19
The results from the present study illustrate
how few the number of clinical signs of nail disease
are and how delusive they can be. All 81 patients
enrolled in the study presented with nail signs com-
patible with the clinical diagnosis of onychomycosis.
However, only 27.2% had a positive mycological
examination even after repetition of negative results.
This low prevalence of onychomycosis, despite being
suggestive clinical findings, may reveal the contribu-
tory effects of age and vascular disease on nail
changes in patients with chronic leg ulcer.
Significantly, data on the present subject are
scarce. Moreover, different protocols and populations
do not allow a direct comparison with the previously
cited studies. However, the contrast between the clin-
ical findings and the results of the mycological exam-
ination is transversal to these studies and should be
noted. All four studies, including ours, have used
mycological examination to diagnose onychomycosis.
It is considered the standard diagnostic method for
onychomycosis in a clinical setting, since it is inexpen-
sive, noninvasive and accessible.3 The inconsistency in
sensitivity of direct exam and fungal culture is recog-
nized as a possible limitation of the study.
Acknowledging this fact, the repetition of negative





Onychomycosis and tinea pedis 4 4.9
Tinea pedis 2 2.5
Fungal isolates in onychomycosis
Dermatophytes § 13 59.1
Trichophyton interdigitale 9 40,9
Trichophyton rubrum 4 18.2
Yeasts § 6 27.2
Candida parapsilosis 4 18.2
Candida albicans 1 4.5
Candida lipolytica 1 4.5
Molds 4 18.2
Scopulariopsis spp 4 18.2
TABLE 2: Results of mycological examination
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As in the general population, most onychomi-
cosis cases were caused by dermatophytes,
mainly  Trichophyton interdigitale and  Trichophyton
rubrum.1,3,4,9 The risk of onychomychosis was almost 13
times higher in patients with superficial leuconychia.
Despite the small number of cases in this study, this
could be a more specific reactive pattern to nail
mycotic infection.
To our knowledge, this is the first study
addressing the prevalence of onychomycosis among
patients with chronic leg ulcer and toenail changes. In
this subset of patients, most nail abnormalities were
not onychomycosis. Regarding costs and potential side
effects of systemic treatment, this study further high-
lights the importance of systematic mycological evalu-
ation in patients with leg ulcer and toenail changes, in
order to avoid overtreatment with antifungals. ❑
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